
This calculator is provided for informational and educational purposes only. It is not intended to replace professional medical advice, diagnosis, or treatment. Always consult with a qualified healthcare professional before making any medical decisions. The results from this calculator should be used as a reference guide only and not as the sole basis for clinical decisions.
Clark Level Calculator
Select a Clark Level (I through V) to display the corresponding skin layer anatomy, invasion depth on the reference spectrum, metastatic risk, Breslow thickness approximation, and sentinel lymph node biopsy guidance. Based on the five-level histopathological classification developed by Wallace H. Clark Jr. in 1969 for melanoma invasion depth assessment.
| Clark Level | Layer Description | Metastatic Risk | Typical Breslow | SLNB Guidance |
|---|
| Clark Level | Histological Criteria | Excision Margins | Key Clinical Notes |
|---|
| Breslow Thickness | Typical Clark Level | AJCC T-Category (8th Ed.) | Excision Margin |
|---|---|---|---|
| In situ (0 mm) | Level I | Tis | 0.5 – 1.0 cm |
| Less than 0.5 mm | Level II | T1a | 1 cm |
| 0.5 – 0.75 mm | Level II – III | T1a or T1b | 1 cm |
| 0.76 – 1.0 mm | Level III – IV | T1a or T1b | 1 cm |
| 1.01 – 2.0 mm | Level IV | T2a or T2b | 1 – 2 cm |
| 2.01 – 4.0 mm | Level IV – V | T3a or T3b | 2 cm |
| Greater than 4.0 mm | Level V | T4a or T4b | 2 cm |
| Note: AJCC 8th Edition T-category uses ulceration and mitotic rate, not Clark Level. Breslow-Clark correlations are approximate and site-dependent. | |||
About This Clark Level Calculator
This Clark Level calculator is designed for clinicians, dermatology and oncology students, pathology trainees, and patients seeking to understand a melanoma histopathology report. It covers all five Clark Levels – from Level I (melanoma in situ confined to the epidermis) through Level V (invasion into the subcutaneous fat) – and translates each level into anatomical context, metastatic risk, approximate Breslow thickness range, and sentinel lymph node biopsy guidance. The tool is intended as a melanoma invasion depth reference and educational aid, not a substitute for professional clinical assessment.
The calculator follows the original Clark Level classification described by Wallace H. Clark Jr. and colleagues in 1969, cross-referenced with AJCC staging evolution through the 7th and 8th Editions. The interactive skin anatomy diagram is based on the standard five-layer model of cutaneous architecture: stratum corneum, epidermis, papillary dermis, reticular dermis, and subcutaneous fat. The invasion spectrum bar positions each Clark Level within a colour-coded reference range. The five clinical information cards display the anatomical layer reached, metastatic risk category, typical Breslow thickness range, and SLNB recommendation associated with the selected level.
The tabs below the calculator provide a full severity reference table comparing all five Clark Levels, a clinical criteria breakdown detailing histological definitions and excision margin guidance, and a Breslow thickness comparison table linking approximate Clark Levels to AJCC T-categories. Because Clark Level assessment requires expert histopathological interpretation and prognosis depends on the full set of pathological parameters, all clinical decisions should be made in consultation with a qualified dermatologist, surgical oncologist, or melanoma multidisciplinary team.
Clark Level Calculator – Complete Guide to Melanoma Invasion Depth and Histological Staging
The Clark Level system is a histopathological classification that describes how deeply a melanoma has invaded the layers of the skin. Developed by Wallace H. Clark Jr. and colleagues in 1969, it remains a foundational tool in dermatopathology for characterising the vertical growth phase of melanoma. Unlike the Breslow thickness measurement, which quantifies tumour depth in millimetres, the Clark Level defines invasion in terms of anatomical skin layers – providing a descriptive, structural framework that helps pathologists and oncologists understand the relationship between tumour advancement and prognosis.
Understanding Clark Levels is essential for clinicians, dermatologists, oncologists, and patients navigating a melanoma diagnosis. The five-level classification spans from in situ disease confined to the epidermis through to deep dermal and subcutaneous invasion, with each level carrying distinct prognostic implications.
Historical Background and Development of the Clark Level System
Wallace H. Clark Jr. introduced the Clark Level classification in his landmark 1969 paper published in Cancer Research, based on careful histological analysis of primary cutaneous melanomas. Clark’s work established that the depth of dermal invasion was a critical determinant of metastatic potential and patient survival. His five-level system mapped melanoma progression against the well-defined anatomical architecture of human skin.
For nearly two decades, the Clark Level system was the primary staging tool for primary melanoma. In 1970, Alexander Breslow introduced a complementary measurement – tumour thickness in millimetres – which eventually proved to have stronger independent prognostic value in most studies. The AJCC 8th Edition (2017) removed Clark Level from formal staging criteria, though it continues to be reported by pathologists worldwide as supplementary histological information.
Anatomy of the Skin: The Five Layers in Clark’s System
The epidermis is the outermost, avascular layer composed primarily of keratinocytes. Melanocytes reside in the stratum basale. Because the epidermis contains no blood vessels, tumours confined here cannot access the circulatory system.
The papillary dermis is the upper dermis, characterised by fine loosely arranged collagen fibres and capillary loops. The reticular dermis lies below it, defined by thick densely packed collagen bundles and larger blood vessels and lymphatics. Below the dermis lies the subcutaneous fat, composed of adipose tissue with extensive vasculature.
Clark Level I – Melanoma In Situ
Clark Level I melanoma is confined entirely to the epidermis. The atypical melanocytic proliferation has not crossed the basement membrane separating the epidermis from the dermis. Because the epidermis is avascular, Level I melanoma has no direct access to blood vessels or lymphatics, making metastatic spread essentially impossible at this stage. These lesions are curable with adequate surgical excision in virtually all cases, with survival rates approaching 100%.
Clark Level II – Invasion into the Papillary Dermis
At Level II, tumour cells have penetrated the basement membrane and entered the papillary dermis, but do not yet fill or expand this layer. The breach of the basement membrane is the critical transition – it represents the point at which melanoma becomes technically “invasive.” Even at this stage, the prognostic implications are relatively favourable, particularly for thin tumours.
Clark Level III – Filling the Papillary Dermis
Level III melanoma expands and fills the papillary dermis, forming a broad front of tumour cells that abuts but does not infiltrate the reticular dermis. The distinction between Level II and Level III can be challenging for pathologists, as it relies on assessment of whether tumour cells merely infiltrate or expansively fill the papillary dermis. Inter-observer variability at this boundary is well-recognised.
Clark Level IV – Invasion into the Reticular Dermis
At Level IV, tumour cells have penetrated between the coarse collagen bundles of the reticular dermis. This is a major progression milestone because the reticular dermis contains larger blood vessels and lymphatics, substantially increasing the risk of haematogenous and lymphatic dissemination. Level IV was the most clinically significant intermediate level, as it was retained as a staging criterion in AJCC 7th Edition guidelines for thin melanomas.
Clark Level V – Invasion into Subcutaneous Fat
Clark Level V represents the deepest category, with tumour cells extending through the full thickness of the dermis and into the subcutaneous adipose tissue. These melanomas are associated with the highest metastatic risk among the Clark categories and typically correspond to Breslow thicknesses greater than 4 mm. Level V melanomas require wide excision, sentinel lymph node biopsy evaluation, and comprehensive systemic staging.
Clark Level describes anatomical invasion by skin layer; Breslow thickness measures the vertical tumour depth in millimetres. Both systems are complementary – Clark Level provides structural context, while Breslow thickness provides a continuous quantitative measurement. Current guidelines prioritise Breslow thickness, mitotic rate, and ulceration for staging, but Clark Level remains reported in many pathology templates.
Clark Level and the AJCC Staging System
In the AJCC 6th Edition (2002), Clark Level IV or V was used to upstage T1 melanomas to T1b status alongside ulceration. The AJCC 7th Edition (2009) retained Clark Level as an alternative T1b criterion when mitotic rate could not be determined. The AJCC 8th Edition (2017), currently in active use, removed Clark Level entirely from staging criteria. T1b designation is now determined by mitotic rate (1 or more per mm2) or ulceration alone. Clark Level no longer formally determines AJCC stage, though it may still appear in pathology reports as supplementary information.
Prognostic Implications by Clark Level
Level I (in situ): Essentially 100% disease-specific survival with complete excision.
Level II: Excellent prognosis. Ten-year survival rates typically exceed 95% for thin Level II tumours.
Level III: Generally favourable, particularly for tumours with Breslow thickness under 1 mm.
Level IV: Moderate risk. Ten-year survival figures vary approximately 60-80% depending on Breslow thickness and other factors.
Level V: Highest risk among Clark categories. Five-year survival may range from 40-60% or lower depending on complete staging findings.
Clark Level classification is subject to inter-observer variability, particularly at the Level II/III and Level III/IV boundaries. The papillary-reticular dermal interface can be histologically ambiguous. This reproducibility concern is a primary reason Breslow thickness has become the dominant staging metric in modern guidelines.
Surgical Margins and Management Guidance
Surgical management of primary melanoma is primarily guided by Breslow thickness. For melanoma in situ (Level I), excision with 0.5 to 1.0 cm margins is typical. For invasive melanoma, margins are determined by Breslow: 1 cm for Breslow thickness 1 mm or less; 1 to 2 cm for Breslow 1.01 to 2.0 mm; 2 cm for Breslow greater than 2.0 mm. Sentinel lymph node biopsy is generally recommended for Breslow thickness greater than 1 mm, and may be considered for 0.8 to 1.0 mm tumours with adverse features.
Global Application and Population Considerations
The Clark Level system applies to cutaneous melanoma at all body sites and in all populations. Acral lentiginous melanoma – the most common subtype in people of African, Asian, and Hispanic ancestry – presents on palms, soles, and subungual regions, where Clark Level classification remains applicable. Mucosal melanoma and uveal melanoma fall outside the Clark system as these sites lack the conventional skin layer architecture the classification requires.
Multiple studies across North America, Europe, Australia, Asia, and South America have confirmed the association between higher Clark Levels and worse prognosis. The fundamental biological principle – that deeper invasion correlates with increased metastatic risk – is consistent across populations.
Frequently Asked Questions
Conclusion
The Clark Level system represents a foundational contribution to melanoma pathology that has shaped understanding of tumour invasion depth for more than five decades. While it has been largely superseded by Breslow thickness and other parameters in formal staging systems, it retains important educational, communicative, and descriptive value in clinical practice and pathology reporting.
Understanding the five Clark Levels provides a structural framework for appreciating how melanoma progresses through the skin and gains access to the vascular and lymphatic channels that enable metastatic spread. It should always be interpreted alongside Breslow thickness, mitotic rate, ulceration, and the full pathological dataset – and clinical decisions should always be made in consultation with qualified healthcare professionals with expertise in melanoma management.
This calculator is provided for informational and educational purposes only. It is not intended to replace professional medical advice, diagnosis, or treatment. Always consult with a qualified healthcare professional before making any medical decisions. The results from this calculator should be used as a reference guide only and not as the sole basis for clinical decisions.